Health

Artemisinin resistance is rising in East Africa—leaving anti-malarials at risk of failure

Resistance to the main drug in front-line malaria treatments is becoming more widespread across East Africa, according to new research by…

Source Medical Xpress AI Summary Updated 1h 30m ago

Story intelligence Beta

Freshness Fresh Updated 1h 30m ago

Confidence Checking

Coverage Checking

Views New Be the first to read

Read time 1 min ~56 words

AI Summary

Resistance to the main drug in front-line malaria treatments is becoming more widespread across East Africa, according to new research by Imperial College London. The study, published in The Lancet Infectious Diseases, maps the rise in artemisinin resistance in the region and suggests one of the safeguards built into these treatments is being eroded. The re…

Read full article on Medicalxpress

AI summaries can be wrong sometimes—always verify important details using the source article.

HAPPENING NOW

Artemisinin resistance is rising in East Africa—leaving anti-malarials at risk of failure

More from Health